Mitchell Sinkler & Starr Abbott Laboratories Transaction History

Mitchell Sinkler & Starr

$353 Million
Q1 2025

A detailed history of Mitchell Sinkler & Starr transactions in Abbott Laboratories stock. As of the latest transaction made, Mitchell Sinkler & Starr holds 92,484 shares of ABT stock, worth $12.4 Million. This represents 3.48% of its overall portfolio holdings.

Number of Shares

92,484

Previous 98,783 6.38%

Holding current value

$12.4 Million

Previous $11.2 Million 9.8%

% of portfolio

3.48%

Previous 3.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	SELL	$111.1 - $140.22 $699,818 - $883,245	-6,299 Reduced 6.38%	92,484 $12.3 Million
Q4 2024 Feb 12, 2025	SELL	$111.93 - $119.39 $1.51 Million - $1.61 Million	-13,501 Reduced 12.02%	98,783 $11.2 Million
Q3 2024 Nov 13, 2024	BUY	$100.07 - $118.13 $171,319 - $202,238	1,712 Added 1.55%	112,284 $12.8 Million
Q2 2024 Aug 07, 2024	BUY	$100.73 - $112.44 $190,581 - $212,736	1,892 Added 1.74%	110,572 $11.5 Million
Q1 2024 Apr 30, 2024	SELL	$109.52 - $120.96 $5.09 Million - $5.62 Million	-46,441 Reduced 29.94%	108,680 $12.4 Million
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $3.17 Million - $3.88 Million	35,131 Added 29.28%	155,121 $17.1 Million
Q3 2023 Nov 01, 2023	SELL	$95.53 - $114.62 $34,486 - $41,377	-361 Reduced 0.3%	119,990 $11.6 Million
Q2 2023 Jul 18, 2023	SELL	$100.78 - $112.29 $198,234 - $220,874	-1,967 Reduced 1.61%	120,351 $13.1 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $943,319 - $1.11 Million	9,739 Added 8.65%	122,318 $12.4 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $570,169 - $668,896	-5,998 Reduced 5.06%	112,579 $12.4 Million
Q3 2022 Oct 25, 2022	SELL	$96.76 - $112.03 $34,833 - $40,330	-360 Reduced 0.3%	118,577 $11.5 Million
Q1 2022 Apr 19, 2022	BUY	$114.02 - $139.04 $146,971 - $179,222	1,289 Added 1.1%	118,937 $14.1 Million
Q4 2021 Feb 01, 2022	BUY	$115.53 - $141.46 $11.4 Million - $13.9 Million	98,323 Added 508.79%	117,648 $16.6 Million
Q3 2021 Oct 12, 2021	SELL	$116.66 - $129.06 $70,812 - $78,339	-607 Reduced 3.05%	19,325 $2.28 Million
Q2 2021 Jul 15, 2021	SELL	$105.79 - $124.53 $21,158 - $24,906	-200 Reduced 0.99%	19,932 $2.31 Million
Q1 2021 Apr 12, 2021	SELL	$108.84 - $128.23 $203,530 - $239,790	-1,870 Reduced 8.5%	20,132 $2.41 Million
Q4 2020 Feb 09, 2021	SELL	$105.0 - $114.42 $378,000 - $411,912	-3,600 Reduced 14.06%	22,002 $2.41 Million
Q3 2020 Oct 07, 2020	BUY	$91.64 - $111.29 $10,996 - $13,354	120 Added 0.47%	25,602 $2.79 Million
Q2 2020 Jul 20, 2020	BUY	$76.57 - $98.0 $24,885 - $31,850	325 Added 1.29%	25,482 $2.33 Million
Q1 2020 Apr 07, 2020	BUY	$62.82 - $91.86 $54,653 - $79,918	870 Added 3.58%	25,157 $1.99 Million
Q4 2019 Jan 09, 2020	SELL	$78.51 - $87.4 $69,088 - $76,912	-880 Reduced 3.5%	24,287 $2.11 Million
Q3 2019 Nov 06, 2019	SELL	$81.84 - $88.74 $286,440 - $310,590	-3,500 Reduced 12.21%	25,167 $2.11 Million
Q2 2019 Jul 17, 2019	SELL	$72.88 - $85.0 $23,613 - $27,540	-324 Reduced 1.12%	28,667 $2.41 Million
Q1 2019 Apr 08, 2019	SELL	$66.22 - $80.06 $197,203 - $238,418	-2,978 Reduced 9.32%	28,991 $2.32 Million
Q4 2018 Jan 24, 2019	SELL	$65.56 - $74.27 $314,753 - $356,570	-4,801 Reduced 13.06%	31,969 $2.31 Million
Q3 2018 Oct 04, 2018	SELL	$60.81 - $73.36 $60,810 - $73,360	-1,000 Reduced 2.65%	36,770 $2.7 Million
Q2 2018 Jul 11, 2018	SELL	$57.57 - $63.54 $40,299 - $44,478	-700 Reduced 1.82%	37,770 $2.3 Million
Q1 2018 Apr 13, 2018	BUY	$56.27 - $63.62 $860,818 - $973,258	15,298 Added 66.02%	38,470 $2.31 Million
Q3 2017 Oct 23, 2017	BUY	$48.06 - $53.64 $1.11 Million - $1.24 Million	23,172	23,172 $1.24 Million

Others Institutions Holding ABT

# of Institutions

3,541

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $234B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Sinkler & Starr, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Sinkler & Starr with notifications on news.

Account

Mitchell Sinkler & Starr Abbott Laboratories Transaction History